Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8

specific

Stage III includes: (T3, N1, M0); (T1-3, N2, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)

22

Centers

22

Active Trials

Cancer Funding

Top Centers for Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8(22)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.8
2
NCI Comprehensive
Active Research Program
52.3
3
NCI Comprehensive
Active Research Program
52.3
4
NCI Comprehensive
Active Research Program
52.3
5
NCI Comprehensive
Active Research Program
52.3
6
NCI Comprehensive
Active Research Program
52.3
7
NCI Comprehensive
Active Research Program
52.3
852.3
9
NCI Comprehensive
Active Research Program
52.3
10
NCI Comprehensive
Active Research Program
52.3
11
NCI Comprehensive
Active Research Program
52.3
12
NCI Clinical
Active Research Program
52.3
13
NCI Comprehensive
Active Research Program
52.3
14
Active Research Program
52.3
15
Active Research Program
52.3
16
Active Research Program
52.3
17
Active Research Program
52.3
18
NCI Comprehensive
Active Research Program
52.3
19
Active Research Program
52.3
20
Active Research Program
52.3
21
Active Research Program
52.3
22
NCI Comprehensive
30.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →